Cite

HARVARD Citation

    Smith, J. et al. (n.d.). P.036 Targeted molecular therapy with quinidine for seizures in a neonate with KCNT1 mutation leads to poor response. Canadian journal of neurological sciences. pp. S22-S23. [Online]. 
  
Back to record